FDA
-
-
-
-
-
-
-
BriaCell completes manufacturing of prostate cancer therapy supplies
-
-
-
-
-
-
-
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
-
-
-
-
-
-
-
BriaCell receives fourth positive safety board recommendation for phase 3 study
-
-
-
-
-
-
-
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Briacell Therapeutics (BCTX)
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Study
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Announces $4M Strategic Investment with Prevail Partners
-
334,854 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


